Exact Sciences (EXAS)
(Delayed Data from NSDQ)
$56.72 USD
+0.53 (0.94%)
Updated Oct 3, 2025 04:00 PM ET
After-Market: $56.60 -0.12 (-0.21%) 7:58 PM ET
3-Hold of 5 3
C Value A Growth B Momentum A VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/04/2025
Time: -- |
9/2025 | $0.10 | 32.65% |
Earnings Summary
For their last quarter, Exact Sciences (EXAS) reported earnings of $0.22 per share, beating the Zacks Consensus Estimate of $-0.02 per share. This reflects a positive earnings surprise of #######%. Look out for EXAS's next earnings release expected on November 04, 2025. For the next earning release, we expect the company to report earnings of $0.10 per share, reflecting a year-over-year increase of 147.62%.
Earnings History
Price & Consensus
Zacks News for EXAS
Exact Sciences (EXAS) Just Flashed Golden Cross Signal: Do You Buy?
EXAS: What are Zacks experts saying now?
Zacks Private Portfolio Services
DGX's Haystack Oncology Teams Up With Rutgers Cancer Institute
Why Exact Sciences (EXAS) is a Top Momentum Stock for the Long-Term
Why Exact Sciences (EXAS) is a Top Growth Stock for the Long-Term
EXAS FAQs
Based on past history, Zacks believes Exact Sciences Corporation (EXAS) will report their next quarter earnings on November 04, 2025. For the next earning release, we expect the company to report earnings of 0.10 per share, reflecting a year-over-year increase of 147.62.
Based on past history, Zacks believes Exact Sciences Corporation (EXAS) will report their previous quarter earnings %%TIME_OF_DAY_CODE%% on November 04, 2025.
The Zacks Consensus Estimate for Exact Sciences Corporation (EXAS) for the quarter ending in September 2025 is $0.10 a share. We expect Exact Sciences Corporation to miss by 32.65%.
In the earnings report for the quarter ending in June 2024, Exact Sciences Corporation (EXAS) announced earnings of $-0.09 per share versus the Zacks Consensus Estimate of $-0.37 per share, representing a surprise of -75.68%.